| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |